Literature DB >> 26857512

Which Patients Will Benefit?

Sotirios Spiliopoulos, Reiner Körfer, Gero Tenderich.   

Abstract

Entities:  

Year:  2016        PMID： 26857512      PMCID： PMC4748151          DOI： 10.3238/arztebl.2016.0039a

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  4 in total

1.  Door-to-balloon time and mortality among patients undergoing primary PCI.

Authors:  Daniel S Menees; Eric D Peterson; Yongfei Wang; Jeptha P Curtis; John C Messenger; John S Rumsfeld; Hitinder S Gurm
Journal:  N Engl J Med       Date:  2013-09-05       Impact factor: 91.245

Review 2.  De novo acute heart failure and acutely decompensated chronic heart failure.

Authors:  Astrid Hummel; Klausn Empe; Marcus Dörr; Stephan B Felix
Journal:  Dtsch Arztebl Int       Date:  2015-04-24       Impact factor: 5.594

3.  One-year survival following early revascularization for cardiogenic shock.

Authors:  J S Hochman; L A Sleeper; H D White; V Dzavik; S C Wong; V Menon; J G Webb; R Steingart; M H Picard; M A Menegus; J Boland; T Sanborn; C E Buller; S Modur; R Forman; P Desvigne-Nickens; A K Jacobs; J N Slater; T H LeJemtel
Journal:  JAMA       Date:  2001-01-10       Impact factor: 56.272

4.  Intraaortic balloon support for myocardial infarction with cardiogenic shock.

Authors:  Holger Thiele; Uwe Zeymer; Franz-Josef Neumann; Miroslaw Ferenc; Hans-Georg Olbrich; Jörg Hausleiter; Gert Richardt; Marcus Hennersdorf; Klaus Empen; Georg Fuernau; Steffen Desch; Ingo Eitel; Rainer Hambrecht; Jörg Fuhrmann; Michael Böhm; Henning Ebelt; Steffen Schneider; Gerhard Schuler; Karl Werdan
Journal:  N Engl J Med       Date:  2012-08-26       Impact factor: 91.245
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.